1. Home
  2. PRQR vs FLL Comparison

PRQR vs FLL Comparison

Compare PRQR & FLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • FLL
  • Stock Information
  • Founded
  • PRQR 2012
  • FLL 1987
  • Country
  • PRQR Netherlands
  • FLL United States
  • Employees
  • PRQR 166
  • FLL N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • FLL Hotels/Resorts
  • Sector
  • PRQR Health Care
  • FLL Consumer Discretionary
  • Exchange
  • PRQR Nasdaq
  • FLL Nasdaq
  • Market Cap
  • PRQR 244.4M
  • FLL 154.7M
  • IPO Year
  • PRQR 2014
  • FLL 1993
  • Fundamental
  • Price
  • PRQR $2.26
  • FLL $4.69
  • Analyst Decision
  • PRQR Strong Buy
  • FLL Strong Buy
  • Analyst Count
  • PRQR 8
  • FLL 4
  • Target Price
  • PRQR $8.88
  • FLL $6.25
  • AVG Volume (30 Days)
  • PRQR 342.1K
  • FLL 470.0K
  • Earning Date
  • PRQR 08-07-2025
  • FLL 08-07-2025
  • Dividend Yield
  • PRQR N/A
  • FLL N/A
  • EPS Growth
  • PRQR N/A
  • FLL N/A
  • EPS
  • PRQR N/A
  • FLL N/A
  • Revenue
  • PRQR $21,212,711.00
  • FLL $297,199,000.00
  • Revenue This Year
  • PRQR N/A
  • FLL $8.61
  • Revenue Next Year
  • PRQR N/A
  • FLL $8.22
  • P/E Ratio
  • PRQR N/A
  • FLL N/A
  • Revenue Growth
  • PRQR 85.91
  • FLL 13.92
  • 52 Week Low
  • PRQR $1.07
  • FLL $2.86
  • 52 Week High
  • PRQR $4.62
  • FLL $5.90
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 56.82
  • FLL 69.17
  • Support Level
  • PRQR $2.27
  • FLL $4.41
  • Resistance Level
  • PRQR $2.51
  • FLL $4.36
  • Average True Range (ATR)
  • PRQR 0.13
  • FLL 0.21
  • MACD
  • PRQR -0.00
  • FLL 0.04
  • Stochastic Oscillator
  • PRQR 51.49
  • FLL 99.55

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About FLL Full House Resorts Inc.

Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.

Share on Social Networks: